PubRank

F Latif

Author PubWeight™ 151.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Isolation and regional localization of a large collection (2,000) of single-copy DNA fragments on human chromosome 3 for mapping and cloning tumor suppressor genes. Hum Genet 1991 12.52
2 Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat Genet 1994 10.14
3 Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci U S A 1994 8.47
4 Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet 2001 4.71
5 Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 2001 4.14
6 Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. Cancer Res 1994 3.62
7 Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma. Biochim Biophys Acta 1996 2.64
8 High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints. Cancer Res 2000 2.60
9 Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Hum Mol Genet 1994 2.52
10 Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene 2001 2.22
11 Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma. Eur J Cancer 2002 1.95
12 Evaluation of the 3p21.3 tumour-suppressor gene cluster. Oncogene 2007 1.86
13 Identification of the promoter of the human von Hippel-Lindau disease tumor suppressor gene. Oncogene 1995 1.82
14 Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma. Oncogene 2010 1.69
15 Germline SDHD mutation in familial phaeochromocytoma. Lancet 2001 1.62
16 Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc Natl Acad Sci U S A 1992 1.56
17 Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3: progress toward the isolation of a lung cancer TSG. Cancer Res 1996 1.55
18 Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma. Oncogene 2010 1.52
19 Molecular and cellular characterization of human renal cell carcinoma cell lines. Cancer Res 1992 1.52
20 Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns. Proc Natl Acad Sci U S A 1996 1.48
21 RASSF6 is a novel member of the RASSF family of tumor suppressors. Oncogene 2007 1.48
22 Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect. Hum Genet 1995 1.42
23 Homozygous deletions at 3p12 in breast and lung cancer. Oncogene 1998 1.42
24 Epigenetic inactivation of SLIT3 and SLIT1 genes in human cancers. Br J Cancer 2004 1.42
25 Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours. Hum Genet 1994 1.41
26 Molecular genetic analysis of the 3p- syndrome. Hum Mol Genet 1994 1.40
27 Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour. Br J Cancer 2005 1.39
28 Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. Cancer Res 1991 1.38
29 Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene. Oncogene 1998 1.38
30 Clinical and molecular genetic analysis of 19 Wolfram syndrome kindreds demonstrating a wide spectrum of mutations in WFS1. Am J Hum Genet 1999 1.37
31 Functional properties of a new voltage-dependent calcium channel alpha(2)delta auxiliary subunit gene (CACNA2D2). J Biol Chem 2000 1.36
32 Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma. Cancer Res 2001 1.35
33 CALL gene is haploinsufficient in a 3p- syndrome patient. Am J Med Genet 1999 1.33
34 The neuronal repellent SLIT2 is a target for repression by EZH2 in prostate cancer. Oncogene 2010 1.29
35 3pK, a new mitogen-activated protein kinase-activated protein kinase located in the small cell lung cancer tumor suppressor gene region. Mol Cell Biol 1996 1.25
36 Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma. Br J Cancer 2008 1.23
37 Prevalence of rheumatic heart disease in school children of urban Lahore. Heart 2008 1.19
38 Detailed mapping of germline deletions of the von Hippel-Lindau disease tumour suppressor gene. Hum Mol Genet 1994 1.18
39 Localization of the von Hippel-Lindau disease gene to a small region of chromosome 3. Genomics 1990 1.18
40 WFS1/wolframin mutations, Wolfram syndrome, and associated diseases. Hum Mutat 2001 1.17
41 RASSF2 associates with and stabilizes the proapoptotic kinase MST2. Oncogene 2009 1.16
42 Epigenetic analysis of HIC1, CASP8, FLIP, TSP1, DCR1, DCR2, DR4, DR5, KvDMR1, H19 and preferential 11p15.5 maternal-allele loss in von Hippel-Lindau and sporadic phaeochromocytomas. Endocr Relat Cancer 2005 1.14
43 Screening for von Hippel-Lindau disease by DNA polymorphism analysis. JAMA 1992 1.14
44 RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours. Oncogene 2001 1.12
45 Genetic linkage between von Hippel-Lindau disease and three microsatellite polymorphisms refines the localisation of the VHL locus. Hum Mol Genet 1993 1.10
46 Analysis of the Birt-Hogg-Dubé (BHD) tumour suppressor gene in sporadic renal cell carcinoma and colorectal cancer. J Med Genet 2003 1.10
47 The RASSF8 candidate tumor suppressor inhibits cell growth and regulates the Wnt and NF-kappaB signaling pathways. Oncogene 2010 1.10
48 SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma. Br J Cancer 2004 1.10
49 MspI and DraI polymorphisms at the ERBA beta locus on chromosome 3p. Nucleic Acids Res 1990 1.10
50 Clinical and molecular analyses of deletion 3p25-pter syndrome. Am J Med Genet 1993 1.10
51 Mapping of the von Hippel-Lindau disease locus to a small region of chromosome 3p by genetic linkage analysis. Genomics 1991 1.09
52 cDNA cloning and expression of the human homolog of the sea urchin fascin and Drosophila singed genes which encodes an actin-bundling protein. DNA Cell Biol 1994 1.08
53 Epigenetic inactivation of the RASSF10 candidate tumor suppressor gene is a frequent and an early event in gliomagenesis. Oncogene 2010 1.08
54 Cloning, mapping, expression, function, and mutation analyses of the human ortholog of the hamster putative tumor suppressor gene Doc-1. J Biol Chem 1998 1.07
55 Epigenetic regulation of the ras effector/tumour suppressor RASSF2 in breast and lung cancer. Oncogene 2007 1.06
56 Detailed mapping of a congenital heart disease gene in chromosome 3p25. J Med Genet 2000 1.05
57 The DUTT1 gene, a novel NCAM family member is expressed in developing murine neural tissues and has an unusually broad pattern of expression. Mol Cell Neurosci 1998 1.03
58 Role of chromosome 3p12-p21 tumour suppressor genes in clear cell renal cell carcinoma: analysis of VHL dependent and VHL independent pathways of tumorigenesis. Mol Pathol 2000 1.02
59 Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer. Cancer Res 1999 1.02
60 Expression of the Von Hippel-Lindau tumor suppressor gene, VHL, in human fetal kidney and during mouse embryogenesis. Mol Med 1995 1.01
61 Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines. Oncogene 1994 0.98
62 Von Hippel-Lindau (VHL) disease: distinct phenotypes suggest more than one mutant allele at the VHL locus. Hum Genet 1991 0.98
63 Molecular genetic analysis of FIH-1, FH, and SDHB candidate tumour suppressor genes in renal cell carcinoma. J Clin Pathol 2004 0.97
64 A genetic linkage map of 96 loci on the short arm of human chromosome 3. Genomics 1992 0.96
65 Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma. Br J Cancer 2004 0.96
66 Analysis of CRELD1 as a candidate 3p25 atrioventicular septal defect locus (AVSD2). Clin Genet 2005 0.95
67 Opposite association of two PPARG variants with cancer: overrepresentation of H449H in endometrial carcinoma cases and underrepresentation of P12A in renal cell carcinoma cases. Hum Genet 2001 0.94
68 Detailed genetic and physical map of the 3p chromosome region surrounding the familial renal cell carcinoma chromosome translocation, t(3;8)(p14.2;q24.1). Cancer Res 1993 0.93
69 Chromosome 3p allele loss in early invasive breast cancer: detailed mapping and association with clinicopathological features. Mol Pathol 2001 0.92
70 Identification of novel VHL targets that are associated with the development of renal cell carcinoma. Oncogene 2006 0.90
71 Presymptomatic diagnosis of von Hippel-Lindau disease with flanking DNA markers. J Med Genet 1992 0.90
72 Molecular genetic studies of sporadic and familial renal cell carcinoma. Urol Clin North Am 1993 0.90
73 Genetic basis of renal cell cancer. Important Adv Oncol 1993 0.88
74 Detailed genetic mapping of the von Hippel-Lindau disease tumour suppressor gene. J Med Genet 1993 0.87
75 Mapping the Von Hippel-Lindau disease tumour suppressor gene: identification of germline deletions by pulsed field gel electrophoresis. Hum Mol Genet 1993 0.87
76 TaqI and PstI RFLPs in the von Hippel-Lindau disease gene (VHL). Hum Mol Genet 1993 0.86
77 Microsatellite instability and mutational analysis of transforming growth factor beta receptor type II gene (TGFBR2) in sporadic ovarian cancer. Mol Pathol 2001 0.85
78 Mutations in the MECP2 gene in a cohort of girls with Rett syndrome. J Med Genet 2000 0.85
79 Isolation and characterization of the full-length 3' untranslated region of the human von Hippel-Lindau tumor suppressor gene. Hum Genet 1996 0.84
80 Rett syndrome and the MECP2 gene. J Med Genet 2001 0.84
81 Kinetics of improved productivity of beta-galactosidase by a cycloheximide-resistant mutant of Kluyveromyces marxianus. Biotechnol Lett 2004 0.83
82 Genetic and functional analysis of the von Hippel-Lindau (VHL) tumour suppressor gene promoter. J Med Genet 2002 0.82
83 Kinetics of enhanced ethanol productivity using raw starch hydrolyzing glucoamylase from Aspergillus niger mutant produced in solid state fermentation. Lett Appl Microbiol 2004 0.81
84 Novel thermodynamics of xylanase formation by a 2-deoxy-d-glucose resistant mutant of Thermomyces lanuginosus and its xylanase potential for biobleachability. Bioresour Technol 2009 0.81
85 Developmental delay and the methyl binding genes. J Med Genet 2003 0.80
86 One-megabase yeast artificial chromosome and 400-kilobase cosmid-phage contigs containing the von Hippel-Lindau tumor suppressor and Ca(2+)-transporting adenosine triphosphatase isoform 2 genes. Cancer Res 1994 0.79
87 von Hippel-Lindau disease: identification of deletion mutations by pulsed-field gel electrophoresis. Hum Genet 1993 0.79
88 Three polymorphic dinucleotide repeats near the von Hippel Lindau (VHL) disease gene on human chromosome 3: D3S587; D3S1317; D3S1435. Hum Mol Genet 1993 0.78
89 Genome-wide DNA methylation profiling of recurrent and non-recurrent chordomas. Epigenetics 2015 0.77
90 A new polymorphic probe on chromosome 3p: lambda LIB28-77 (D3S169E). Nucleic Acids Res 1990 0.77
91 Identification of a single nucleotide polymorphism in the human alpha 2 delta 2 calcium channel subunit gene. Mol Cell Probes 2001 0.77
92 Physical mapping of chromosome 3p25-p26 by fluorescence in situ hybridisation (FISH). Hum Genet 1993 0.77
93 DNA strand breaks induced by configurationally isomeric hydrocarbon diol epoxides. Drug Metab Rev 1994 0.76
94 Long range restriction map of the von Hippel-Lindau gene region on human chromosome 3p. Hum Genet 1993 0.76
95 Choroidal hemorrhage at vitrectomy. Ophthalmology 1994 0.75
96 Mutation screening analysis of the retinoblastoma related gene RB2/p130 in sporadic ovarian cancer and head and neck squamous cell cancer. Mol Pathol 2002 0.75
97 A new polymorphic probe on chromosome 3p: lambda LIB17-11 (D3S1092). Nucleic Acids Res 1991 0.75
98 A new polymorphic probe on chromosome 3p: lambda LIB50-50' (D3S1099). Nucleic Acids Res 1991 0.75
99 A new polymorphic probe on chromosome 3p: lambda LIB36-68 (D3S615). Nucleic Acids Res 1991 0.75
100 A new polymorphic probe on chromosome 3p: lambda LIB4-59 (D3S575). Nucleic Acids Res 1991 0.75
101 A new polymorphic probe on chromosome 3p: lambda LIB18-88 (D3S1093). Nucleic Acids Res 1991 0.75
102 A new polymorphic probe on chromosome 3p: lambda LIB46-27' (D3S635). Nucleic Acids Res 1991 0.75
103 A new polymorphic probe on chromosome 3p:lambda LIB28-62(D3S736). Nucleic Acids Res 1991 0.75
104 A new polymorphic probe on chromosome 3p: lambda LIB09-75' (D3S584). Nucleic Acids Res 1991 0.75
105 A new polymorphic probe on chromosome 3p: lambda LIB34-60 [D3S154]. Nucleic Acids Res 1989 0.75
106 A new polymorphic probe on chromosome 3p: lambda LIB24-12' (D3S727). Nucleic Acids Res 1991 0.75
107 A new polymorphic probe on chromosome 3p: lambda LIB32-90' (D3S216). Nucleic Acids Res 1990 0.75
108 Dose-dependent blockade of the angiotensin II type 1 receptor with losartan in normal volunteers. J Cardiovasc Pharmacol 2001 0.75
109 A new polymorphic probe on chromosome 3p: lambda LIB49-63 (D3S192E). Nucleic Acids Res 1990 0.75
110 A new polymorphic probe on chromosome 3p: lambda LIB19-63' (D3S601). Nucleic Acids Res 1991 0.75
111 [Twenty-five statements on early initiation of fixed combination ICS/LABA treatment for asthma and COPD in primary and secondary care: consensus research by a modified Delphi process]. Pneumologie 2012 0.75
112 Formation of diazopeptides by nitrogen oxides. IARC Sci Publ 1987 0.75
113 Colocalization of the rat homolog of the von Hippel Lindau (Vhl) gene and the plasma membrane Ca++ transporting ATPase isoform 2 (Atp2b2) gene to rat chromosome bands 4q41.3-->42.1. Cytogenet Cell Genet 1995 0.75